ClinicalTrials.gov
ClinicalTrials.gov Menu

Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01723202
Recruitment Status : Active, not recruiting
First Posted : November 7, 2012
Last Update Posted : April 11, 2018
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Manisha Shah, Ohio State University Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : December 31, 2019